Michael Brownlee

46.2k citations
112 papers · 38.2k · 14 hit papers · h-index 61

Impact in

Papers in

Michael Brownlee

110 papers receiving 36.4k citations

Michael Brownlee's Hit Papers

Diabetic kidney disease 2015 · 918 citations
9180+14+28Years since publication2.5k5k7.5k

Peers

Michael Brownlee
Comparison fields: 5 of 163
  • Clinical Biochemistry 6.6k
  • Endocrinology, Diabetes and Metabolism 6.6k
  • Nephrology 3.6k
  • Ophthalmology 2.7k
  • Biochemistry 1.5k
Replace George Liang King with:
George Liang King United States
Ann Marie Schmidt United States
Sho‐ichi Yamagishi Japan
Helen Vlassara United States
Mark Emmanuel Cooper Australia
John Baynes United States
Angelika Bierhaus Germany
Paul John Thornalley United Kingdom
Casper G. Schalkwijk Netherlands
Csaba Szabó United States
Michael Brownlee relative to George Liang King United States George Liang King's profile →
Citations per field
00.5×2×3.1×
George Liang King · 1×
Citations per year

Countries citing papers authored by Michael Brownlee

Since Specialization
Citations

This map shows the geographic impact of Michael Brownlee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Brownlee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Brownlee more than expected).

Fields of papers citing papers by Michael Brownlee

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Brownlee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Brownlee. The network helps show where Michael Brownlee may publish in the future.

Co-authors

The 25 scholars most cited alongside Michael Brownlee, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Michael Brownlee Line = papers co-authored together Michael Brownlee links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 112 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Biochemistry and molecular cell biology of diabetic complications
Hit paper breakdown →
20017582
2
Oxidative Stress and Diabetic Complications
Hit paper breakdown →
20104496
3
The Pathobiology of Diabetic Complications
Hit paper breakdown →
20054400
4
Advanced Glycosylation End Products in Tissue and the Biochemical Basis of Diabetic Complications
Hit paper breakdown →
19882223
5
The adipocyte-secreted protein Acrp30 enhances hepatic insulin action
Hit paper breakdown →
20012158
6
Hyperglycemia-induced mitochondrial superoxide overproduction activates the hexosamine pathway and induces plasminogen activator inhibitor-1 expression by increasing Sp1 glycosylation
Hit paper breakdown →
2000949
7
Structure-Function Studies of the Adipocyte-secreted Hormone Acrp30/Adiponectin
Hit paper breakdown →
2003935
8
Diabetic kidney disease
Hit paper breakdown →
2015918
9
Nonenzymatic Glycosylation and the Pathogenesis of Diabetic Complications
Hit paper breakdown →
1984896
10
Inhibition of GAPDH activity by poly(ADP-ribose) polymerase activates three major pathways of hyperglycemic damage in endothelial cells
Hit paper breakdown →
2003707
11
Benfotiamine blocks three major pathways of hyperglycemic damage and prevents experimental diabetic retinopathy
Hit paper breakdown →
2003664
12 1994561
13
Cachectin/TNF and IL-1 Induced by Glucose-Modified Proteins: Role in Normal Tissue Remodeling
Hit paper breakdown →
1988521
14
Hyperglycemia-Induced Reactive Oxygen Species Increase Expression of the Receptor for Advanced Glycation End Products (RAGE) and RAGE Ligands
Hit paper breakdown →
2009442
15 2000441
16 1992428
17 2004417
18 2006406
19 2009405
20 2009396

About Michael Brownlee

Michael Brownlee is a scholar working on Clinical Biochemistry, Endocrinology, Diabetes and Metabolism, Nephrology, Ophthalmology and Physiology, having authored 112 papers that have together received 38.2k indexed citations. Recurring topics across this work include Advanced Glycation End Products research (54 papers), Diabetes Management and Research (15 papers), Nitric Oxide and Endothelin Effects (8 papers), Chronic Kidney Disease and Diabetes (8 papers), Virus-based gene therapy research (8 papers), Retinal Diseases and Treatments (8 papers), Angiogenesis and VEGF in Cancer (6 papers) and Pancreatic function and diabetes (4 papers). The work is most often cited by research in Clinical Biochemistry (6.6k citations), Endocrinology, Diabetes and Metabolism (6.6k citations), Nephrology (3.6k citations), Ophthalmology (2.7k citations) and Biochemistry (1.5k citations). Michael Brownlee has collaborated with scholars based in United States, Germany and Japan. Frequent co-authors include Ferdinando Giacco, Anthony Cerami, Helen Vlassara, Xueliang Du, Diane Edelstein, Anders Hayden Berg, Philipp E. Scherer, Terry P. Combs, Lisa H. Underhill and Jeffrey S. Flier. Their work appears in journals such as Diabetes, Journal of Biological Chemistry, Diabetes Care, Circulation Research and The Lancet.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact